A Phase II/III, randomized, controlled, single blind study to evaluate the haemostatic efficacy and safety of topically applied TT-173 in patients undergoing knee arthroplasty

Trial Profile

A Phase II/III, randomized, controlled, single blind study to evaluate the haemostatic efficacy and safety of topically applied TT-173 in patients undergoing knee arthroplasty

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Feb 2016

At a glance

  • Drugs TT 173 (Primary)
  • Indications Blood coagulation disorders
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms HESTAT
  • Sponsors Thrombotargets Corporation
  • Most Recent Events

    • 21 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top